BioScrip (BIOS) PT Raised to $3.50 at Craig-Hallum
Craig-Hallum raised its price target on BioScrip (NASDAQ: BIOS) to $3.50 while maintaining a Buy rating.
Analyst Kevin Ellich likes the effort from management to clean up it's operations. The analyst believes Q4 results were good and thinks FY 2018 guidance is conservative.